United States

Showing 51-60 of 345 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Broad Scope CMC, Non-Clinical, and Regulatory Support	Dark Horse Consulting	Nathan Manley	Cures	01-September-2025 to 31-December-2026	$85,000.00
Brown University IND Readiness Gap Analysis	Dark Horse Consulting	Nathan Manley	Cures	01-June-2025 to 31-December-2025	$87,770.00
Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling	Duke University	Rhonda Merwin	Improving Lives	01-July-2022 to 30-June-2027	$2,758,224.22
ACTin1 for DD: Developing and Testing a Digital Single Session Acceptance and Commitment Therapy Intervention for Type 1 Diabetes Distress	Duke University	Max Roberts	Improving Lives	01-April-2026 to 31-March-2029	$241,710.00
Impact of Inflammatory Cytokines on ER-Mitochondria Crosstalk and Proinsulin Folding in Beta Cells	East Tennessee State University	Anoop Arunagiri	Cures	01-August-2025 to 31-July-2027	$241,431.00
Evaluating the Effectiveness and Safety of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 1 Diabetes	Emory University	Hui Shao	Improving Lives	01-July-2025 to 30-June-2027	$599,998.91
Stromal Cell Targeted Tolerogenic mRNA Therapy for T1D	Endotope Biosciences	Raymond Liang	Cures	15-December-2025 to —	$550,417.82
Subcutaneous In Vivo Engraftment and Vascularization of 3D Bioprinted Pancreatic-Like Tissue	FluidForm Bio	Adam Feinberg	Cures	23-December-2025 to 12-June-2026	$228,696.00
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population	Geisinger Clinic	David Carey	Cures	01-November-2022 to 30-September-2026	$1,469,640.10
GNTI-122 for the treatment of recently diagnosed type 1 diabetes	GentiBio	Mark Bach	Cures	01-December-2025 to 30-November-2027	$4,000,000.00